JASON ERIKSEN's research topics

JASON ERIKSEN

Concepts (329)

Back to Profile

Concepts are derived automatically from a person's publications.

The timeline below shows the dates (blue tick marks) of publications associated with JASON ERIKSEN's top concepts. The average publication date for each concept is shown as a red circle, illustrating changes in the primary topics that JASON ERIKSEN has written about over time.

Central Nervous System Depressants, 4 publications between 1999 and 2003, average publication date April 2001. Ethanol, 6 publications between 1999 and 2003, average publication date August 2001. Buspirone, 4 publications between 2000 and 2002, average publication date September 2001. Nerve Growth Factors, 4 publications between 2000 and 2002, average publication date September 2001. S100 Proteins, 4 publications between 2000 and 2002, average publication date September 2001. Serotonin Receptor Agonists, 5 publications between 2000 and 2003, average publication date January 2002. Astrocytes, 4 publications between 2001 and 2003, average publication date May 2002. Amyloid beta-Peptides, 16 publications between 2001 and 2018, average publication date November 2007. Intercellular Signaling Peptides and Proteins, 4 publications between 2006 and 2009, average publication date March 2008. Neurodegenerative Diseases, 4 publications between 2007 and 2012, average publication date July 2009. tau Proteins, 8 publications between 2005 and 2022, average publication date August 2009. Mice, Transgenic, 15 publications between 2001 and 2022, average publication date February 2010. Memory Disorders, 4 publications between 2006 and 2013, average publication date April 2010. Plaque, Amyloid, 6 publications between 2005 and 2018, average publication date March 2011. Alzheimer Disease, 18 publications between 2001 and 2022, average publication date July 2011. alpha-Synuclein, 6 publications between 2003 and 2021, average publication date February 2012. Fixatives, 1 publications between 2015 and 2015, average publication date November 2015. Histocytochemistry, 1 publications between 2015 and 2015, average publication date November 2015. Imidazolidines, 1 publications between 2015 and 2015, average publication date November 2015. Tromethamine, 1 publications between 2015 and 2015, average publication date November 2015.

Central Nervous System Depressants
Ethanol
Buspirone
Nerve Growth Factors
S100 Proteins
Serotonin Receptor Agonists
Astrocytes
Amyloid beta-Peptides
Intercellular Signaling Peptides and Proteins
Neurodegenerative Diseases
tau Proteins
Mice, Transgenic
Memory Disorders
Plaque, Amyloid
Alzheimer Disease
alpha-Synuclein
Fixatives
Histocytochemistry
Imidazolidines
Tromethamine

To see the data from this visualization as text, click here.

Name	Number of Publications	First Publication Year	Most Recent Publication Year	Average Publication Date
Central Nervous System Depressants	4	1999	2003	April 2001
Ethanol	6	1999	2003	August 2001
Buspirone	4	2000	2002	September 2001
Nerve Growth Factors	4	2000	2002	September 2001
S100 Proteins	4	2000	2002	September 2001
Serotonin Receptor Agonists	5	2000	2003	January 2002
Astrocytes	4	2001	2003	May 2002
Amyloid beta-Peptides	16	2001	2018	November 2007
Intercellular Signaling Peptides and Proteins	4	2006	2009	March 2008
Neurodegenerative Diseases	4	2007	2012	July 2009
tau Proteins	8	2005	2022	August 2009
Mice, Transgenic	15	2001	2022	February 2010
Memory Disorders	4	2006	2013	April 2010
Plaque, Amyloid	6	2005	2018	March 2011
Alzheimer Disease	18	2001	2022	July 2011
alpha-Synuclein	6	2003	2021	February 2012
Fixatives	1	2015	2015	November 2015
Histocytochemistry	1	2015	2015	November 2015
Imidazolidines	1	2015	2015	November 2015
Tromethamine	1	2015	2015	November 2015

ERIKSEN's Networks

Click the

Explore

buttons for more information and interactive visualizations!

Concepts (329)

Explore

Co-Authors (26)

Explore

Similar People (60)

Explore

Same Department

Explore

Physical Neighbors